The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D Study
1
Issued Date
2025-01-01
Resource Type
ISSN
01054538
eISSN
13989995
Scopus ID
2-s2.0-105015654737
Journal Title
Allergy European Journal of Allergy and Clinical Immunology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Allergy European Journal of Allergy and Clinical Immunology (2025)
Suggested Citation
Kulthanan K., Bernstein J.A., Rudenko M., Salameh P., Komoltri C., Adışen E., Al Abri S., Al-Ahmad M., Al-Ahmed N., Al Hinai B., Allenova A., Alshareef S., Angkoolpakdeekul N., Arnaout R., Bartosińska J., Cherrez-Ojeda I., Chularojanamontri L., Criado P.R., Ensina L.F., Criado R.F.J., Calle C.A.G., Giménez-Arnau A.M., Godse K., Gotua M., Inomata N., Jantanapornchai N., Jung C.G., Kasperska-Zając A., Khoshkhui M., Kolkhir P., Krasowska D., Laomoleethorn J., Maiorowa A., Meshkova R., Mijakoski D., Munoz M., Nanchaipruek Y., Nasr I., Kara R.Ö., Panjapakkul W., Paringkarn T., Podder I., Robles-Velasco K., Rosmaninho I., Presa A.R., Rujitharanawong C., Saengthong-aram P., Tafrishi R., Mitrevska N.T., Tuchinda P., Wannawittayapa T., Wilson A., Ye Y.M., Zalewska-Janowska A., Maurer M., Zuberbier T. The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D Study. Allergy European Journal of Allergy and Clinical Immunology (2025). doi:10.1111/all.70047 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112138
Title
The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D Study
Author(s)
Kulthanan K.
Bernstein J.A.
Rudenko M.
Salameh P.
Komoltri C.
Adışen E.
Al Abri S.
Al-Ahmad M.
Al-Ahmed N.
Al Hinai B.
Allenova A.
Alshareef S.
Angkoolpakdeekul N.
Arnaout R.
Bartosińska J.
Cherrez-Ojeda I.
Chularojanamontri L.
Criado P.R.
Ensina L.F.
Criado R.F.J.
Calle C.A.G.
Giménez-Arnau A.M.
Godse K.
Gotua M.
Inomata N.
Jantanapornchai N.
Jung C.G.
Kasperska-Zając A.
Khoshkhui M.
Kolkhir P.
Krasowska D.
Laomoleethorn J.
Maiorowa A.
Meshkova R.
Mijakoski D.
Munoz M.
Nanchaipruek Y.
Nasr I.
Kara R.Ö.
Panjapakkul W.
Paringkarn T.
Podder I.
Robles-Velasco K.
Rosmaninho I.
Presa A.R.
Rujitharanawong C.
Saengthong-aram P.
Tafrishi R.
Mitrevska N.T.
Tuchinda P.
Wannawittayapa T.
Wilson A.
Ye Y.M.
Zalewska-Janowska A.
Maurer M.
Zuberbier T.
Bernstein J.A.
Rudenko M.
Salameh P.
Komoltri C.
Adışen E.
Al Abri S.
Al-Ahmad M.
Al-Ahmed N.
Al Hinai B.
Allenova A.
Alshareef S.
Angkoolpakdeekul N.
Arnaout R.
Bartosińska J.
Cherrez-Ojeda I.
Chularojanamontri L.
Criado P.R.
Ensina L.F.
Criado R.F.J.
Calle C.A.G.
Giménez-Arnau A.M.
Godse K.
Gotua M.
Inomata N.
Jantanapornchai N.
Jung C.G.
Kasperska-Zając A.
Khoshkhui M.
Kolkhir P.
Krasowska D.
Laomoleethorn J.
Maiorowa A.
Meshkova R.
Mijakoski D.
Munoz M.
Nanchaipruek Y.
Nasr I.
Kara R.Ö.
Panjapakkul W.
Paringkarn T.
Podder I.
Robles-Velasco K.
Rosmaninho I.
Presa A.R.
Rujitharanawong C.
Saengthong-aram P.
Tafrishi R.
Mitrevska N.T.
Tuchinda P.
Wannawittayapa T.
Wilson A.
Ye Y.M.
Zalewska-Janowska A.
Maurer M.
Zuberbier T.
Author's Affiliation
Charité – Universitätsmedizin Berlin
Universidade Federal de São Paulo
University of Cincinnati College of Medicine
Sechenov First Moscow State Medical University
Universitat Pompeu Fabra Barcelona
Uniwersytet Medyczny w Lodzi
Mashhad University of Medical Sciences
Slaski Uniwersytet Medyczny w Katowicach
Kuwait University
Medical University of Lublin
Siriraj Hospital
King Faisal Specialist Hospital & Research Centre
Sakarya Üniversitesi
Ajou University School of Medicine
Université Libanaise
Showa University School of Medicine
Gazi University, Faculty of Medicine
Keimyung University (KU), College of Medicine
Universidad Espíritu Santo
Ministry of Health Kuwait
Royal Hospital
D Y Patil University, Navi Mumbai
University of Nicosia Medical School
Gilbert and Rose-Marie Chagoury School of Medicine
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Smolensk State Medical Academy
Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban
College of Medicine & Sagore Dutta Hospital
David Tvildiani Medical University
University of Skopje
Unidade Local de Saúde Gaia e Espinho
London Allergy and Immunology Centre
International Balkan University
Centro Universitário Faculdade de Medicina do ABC
Ga2len Collaborating Center
Hospital Center Tâmega e Sousa
General Private Hospital-Remedika
Respiralab Research Group
Emedic Salud
Universidade Federal de São Paulo
University of Cincinnati College of Medicine
Sechenov First Moscow State Medical University
Universitat Pompeu Fabra Barcelona
Uniwersytet Medyczny w Lodzi
Mashhad University of Medical Sciences
Slaski Uniwersytet Medyczny w Katowicach
Kuwait University
Medical University of Lublin
Siriraj Hospital
King Faisal Specialist Hospital & Research Centre
Sakarya Üniversitesi
Ajou University School of Medicine
Université Libanaise
Showa University School of Medicine
Gazi University, Faculty of Medicine
Keimyung University (KU), College of Medicine
Universidad Espíritu Santo
Ministry of Health Kuwait
Royal Hospital
D Y Patil University, Navi Mumbai
University of Nicosia Medical School
Gilbert and Rose-Marie Chagoury School of Medicine
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Smolensk State Medical Academy
Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban
College of Medicine & Sagore Dutta Hospital
David Tvildiani Medical University
University of Skopje
Unidade Local de Saúde Gaia e Espinho
London Allergy and Immunology Centre
International Balkan University
Centro Universitário Faculdade de Medicina do ABC
Ga2len Collaborating Center
Hospital Center Tâmega e Sousa
General Private Hospital-Remedika
Respiralab Research Group
Emedic Salud
Corresponding Author(s)
Other Contributor(s)
Abstract
Background: The prevalence of symptomatic dermographism (SD) in the general population remains unclear. This study aimed to internationally estimate the prevalence of SD and two other dermographic subtypes—physiological red dermographism and simple urticarial dermographism—among adults worldwide. Methods: The PREVALENCE-D (Prevalence Estimation of Dermographism) study was the largest international, cross-sectional, internet-based investigation conducted by the Urticaria Centers of Reference and Excellence of the Global Allergy and Asthma Excellence Network from 2021 to 2024. A world expert-designed questionnaire was completed by participants from 28 centers across 19 countries to diagnose SD. Participants were recruited into three age groups (18–24, 25–60, and > 60 years), with ≥ 1000 individuals per group per country. We calculated sex- and age-adjusted prevalence estimates internationally and by country, with 95% confidence intervals. Results: Among 59,543 participants worldwide, those with SD had an adjusted point prevalence of 3.20% (95% confidence interval [CI] 2.68%–3.73%) and a lifetime prevalence of 5.94% (95% CI 5.32%–6.56%). The 25–60 years group presented the highest prevalence. Females had higher rates than males, with statistically significant differences across all age groups for both point and lifetime prevalence. Physiological red dermographism had an adjusted point prevalence of 10.02% (95% CI 9.48%–10.55%) and a lifetime prevalence of 33.47% (95% CI 32.01%–34.94%). Simple urticarial dermographism showed an adjusted point prevalence of 1.21% (95% CI 1.08%–1.35%) and a lifetime prevalence of 5.39% (95% CI 4.99%–5.79%). Conclusion: These findings provide comprehensive international estimates of dermographism, particularly SD, and emphasize the need for appropriate healthcare resource allocation and disease recognition.